Volume 19 Supplement 1
Mechanisms of tauroursodeoxycholate-mediated inhibition of apoptosis
© Sommerfeld et al; licensee BioMed Central Ltd. 2014
Published: 19 June 2014
The hydrophilic bile acid ursodeoxycholic acid (UDCA), which in vivo is converted to its taurine conjugate tauroursodeoxycholic acid (TUDC), is a mainstay in the treatment of cholestatic liver disease. TUDC prevents bile acid-induced cholestasis and induces choleresis. Its beneficial effects involve an increased hepatobiliary secretion as well as cytoprotective and antiapoptotic effects. The choleretic effect of TUDC largely depends on a rapid targeting and insertion of intracellularly stored transport ATPases into the canalicular membrane, such as the bile salt export pump (Bsep) and multidrug resistance protein-2 (Mrp2) . It was recently shown that the TUDC-induced signaling involves phosphorylation of the epidermal growth factor receptor (EGFR) at tyrosine 845 and 1173, but not Tyr1045. Tyr845, a known Src kinase target, triggers an activating autophosphorylation at Tyr1173 of the EGFR . Furthermore, c-Src, focal adhesion kinase (FAK), phosphatidylinositol 3-kinase (PI3K) and Ras/Raf are activated within minutes by TUDC, which triggers downstream dual activation of extracellular signal-regulated kinases (Erks) and p38 mitogen-activated protein kinase (p38MAPK) [1–4].
Recent data indicate that integrins are a long-searched sensor for TUDC in the liver, because TUDC interacts with α5ß1 integrins in the liver resulting in a conformational change with activation of ß1 integrin and the initiation of downstream integrin signaling. In contrast to the previously reported ß1 integrin activation in response to hypoosmolarity or insulin, TUDC-induced integrin activation occurs inside the hepatocyte and requires TUDC uptake via the basolateral Na+/taurocholate cotransporting polypeptide (Ntcp) . However, other mechanisms of TUDC action may contribute to its choleretic effect under pathological cholestatic conditions.
Hepatocyte apoptosis can be triggered by the retention of hydrophobic bile acids in hepatocytes by activation of ligand-independent death receptor pathways in vivo and in vitro. Toxic bile acids such as taurolithocholyl-3 sulfate (TLCS) and glycochenodeoxycholate (GCDC) have previously been shown to induce apoptosis in a CD95-dependent apoptosis, involving activation of the acidic sphingomyelinase, increased ceramide formation and activation of the protein kinase Cζ (PKCζ) followed by an oxidative stress response via serine phosphorylation of p47phox and NADPH oxidase activation. Putative inhibition of phosphatase activities by reactive oxygen species (ROS) triggers an activation of the Src family kinase Yes and activation of the c-Jun-N-terminal kinase-1/-2 (JNK). The activated Yes kinase associates with the EGFR resulting in a Yes-mediated EGFR transactivation. Activated EGFR then associates in a JNK-dependent way with CD95 and catalyzes CD95 tyrosine phosphorylation, which triggers CD95 membrane trafficking, death-inducing signaling complex (DISC) formation, i.e. association of Fas-associated death domain (FADD) and caspase 8 to the death receptor, followed by caspase 8-dependent mitochondrial amplification of pro-apoptotic signaling, which finally leads to apoptotic cell death .
Bile salt-induced apoptosis can be antagonized by TUDC. This cytoprotective effect of TUDC results from an inhibition of JNK activation and CD95 trafficking to the cell surface and activation of caspases 8 and 9 . However, the molecular basis of TUDC-sensing with regard to anti-apoptosis is not yet settled, but may involve a TUDC-mediated inhibition of bile salt-induced phosphorylation of the MAP kinase kinase 4/7 (MKK4/7) upstream of JNK activation Furthermore, similar to cAMP, TUDC induced a protein kinase A (PKA)-sensitive serine/threonine phosphorylation of the CD95 in presence of GCDC, which was identified as an internalization signal for CD95. Inhibition of hepatocyte apoptosis by cAMP involves both PKA-dependent serine/threonine phosphorylation of the CD95 and inhibition of EGFR activation, which results in an inhibition of CD95 tyrosine phosphorylation, CD95 membrane targeting, and DISC formation. mRNA analyses show that the dual specificity MAP kinase phosphatase MKP-1, a transcriptionally regulated immediate early gene-encoded enzyme, is upregulated in response to TUDC after stimulation with GCDC for up to 60 min, which was already shown for cAMP . Preliminary data suggest that TUDC-induced integrin activation is involved in mediating its anti-apoptotic effect.
- Kurz AK, Graf D, Schmitt M, vom Dahl S, Häussinger D: Tauroursodesoxycholate-induced choleresis involves p38(MAPK) activation and translocation of the bile salt export pump in rats. Gastroenterology 2001, 121: 407–419. 10.1053/gast.2001.26262PubMedView ArticleGoogle Scholar
- Gohlke H, Schmitz B, Sommerfeld A, Reinehr R, Häussinger D: α5ß1-integrins are sensors for tauroursodeoxycholic acid in hepatocytes. Hepatology 2013, 57: 1117–1129. 10.1002/hep.25992PubMedView ArticleGoogle Scholar
- Häussinger D, Kurz AK, Wettstein M, Graf D, vom Dahl S, Schliess F: Involvement of integrins and Src in tauroursodeoxycholate-induced and swelling-induced choleresis. Gastroenterology 2003, 124: 1476–1487. 10.1016/S0016-5085(03)00274-9PubMedView ArticleGoogle Scholar
- Kurz AK, Block C, Graf D, vom Dahl S, Schliess F, Häussinger D: Phosphoinositide 3-kinase-dependent Ras activation by tauroursodesoxycholate in rat liver. Biochem J 2000, 350: 207–13. 10.1042/0264-6021:3500207PubMed CentralPubMedView ArticleGoogle Scholar
- Reinehr R, Häussinger D: CD95 death receptor and epidermal growth factor receptor (EGFR) in liver cell apoptosis and regeneration. Arch Biochem Biophys 2012, 518: 2–7. 10.1016/j.abb.2011.12.004PubMedView ArticleGoogle Scholar
- Graf D, Kurz AK, Fischer R, Reinehr R, Häussinger D: Taurolithocholic acid-3 sulfate induces CD95 trafficking and apoptosis in a c-Jun N-terminal kinase-dependent manner. Gastroenterology 2002, 122: 1411–27. 10.1053/gast.2002.32976PubMedView ArticleGoogle Scholar
- Schliess F, Kurz AK, Häussinger D: Glucagon-induced expression of the MAP kinase phosphatase MKP-1 in rat hepatocytes. Gastroenterology 2000, 18: 929–36.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.